Skip to main content
. 2019 Nov 25;1:100010. doi: 10.1016/j.bbih.2019.100010

Fig. 1.

Fig. 1

Control spleen sections for immunohistochemistry controls with (A) the full protocol and (B) omitting the primary antibody. While no CD68 was observed in negative control sections, all positive control sections displayed robust CD68 staining.